MedPath

BI 409306 in Patients With Cognitive Impairment Due to Alzheimer's Disease.

Phase 2
Completed
Conditions
Alzheimer Disease
Interventions
Registration Number
NCT02337907
Lead Sponsor
Boehringer Ingelheim
Brief Summary

The study is designed to compare the effects of BI 409306 compared to placebo in patients with cognitive impairment due to Alzheimer's Disease

Detailed Description

Not available

Recruitment & Eligibility

Status
COMPLETED
Sex
All
Target Recruitment
329
Inclusion Criteria

Not provided

Exclusion Criteria

Not provided

Study & Design

Study Type
INTERVENTIONAL
Study Design
PARALLEL
Arm && Interventions
GroupInterventionDescription
BI 409306 dose 3BI 409306-
Placebo comparatorPlacebo-
BI 409306 dose 1Placebo-
BI 409306 dose 1BI 409306-
BI 409306 dose 2Placebo-
BI 409306 dose 2BI 409306-
BI 409306 dose 3Placebo-
Active Comparator DonepezilPlacebo-
Active Comparator DonepezilDonepezil-
BI 409306 dose 4Placebo-
BI 409306 dose 4BI 409306-
Primary Outcome Measures
NameTimeMethod
Change From Baseline in Neuropsychological Test Battery in Total Z-score After 12-week Treatment.Baseline and 12 weeks

Neuropsychological Test Battery (NTB) response, defined as change from baseline in total z-score after 12 weeks of treatment. The NTB consists of 9 validated components. Raw scores on each of the 9 NTB tests were converted to z-scores using the baseline means and standard deviations (SDs) for each test. The resultant z-scores were averaged to obtain a total z-score, incorporating all 9 NTB tests. The NTB Z-score indicates the number of standard deviations away from the mean. A Z-score of 0 is equal to the mean at baseline. Negative numbers indicate values lower than baseline and positive numbers indicate values higher than baseline. Least Squares Mean is actually an adjusted mean change from baseline.

Change From Baseline in Neuropsychological Test Battery in Total Z-score After 12-week Treatment From Two Sister Trials, Present 1289.5 (NCT02240693) and 1289.7 (NCT02337907)Baseline and 12 weeks

Neuropsychological Test Battery (NTB) response, defined as change from baseline in total z-score after 12 weeks of treatment. The NTB consists of 9 validated components. Raw scores on each of the 9 NTB tests were converted to z-scores using the baseline means and standard deviations (SDs) for each test. The resultant z-scores were averaged to obtain a total z-score, incorporating all 9 NTB tests. The NTB Z-score indicates the number of standard deviations away from the mean. A Z-score of 0 is equal to the mean at baseline. Negative numbers indicate values lower than baseline and positive numbers indicate values higher than baseline. The number of low test scores decreased with higher levels of intellectual abilities. Least Squares Mean is actually an adjusted mean change from baseline.

Secondary Outcome Measures
NameTimeMethod
Change From Baseline in Alzheimer's Disease Cooperative Study/Activities of Daily Living (ADCS-ADL) Total Score After 12-week TreatmentBaseline and 12 weeks

Alzheimer's Disease Cooperative Study/Activities of Daily Living (ADCS-ADL) is a rating scale used to assess basic and instrumental activities of daily living. In the full version of the scale, 23 items are rated by the investigator using information supplied by the caregiver. Each item has a score range varying from 0-3 to 0-5. The sum score can range from 0 to 78. Higher scores indicate better function. Least Squares Mean is actually an adjusted mean change from baseline.

Change From Baseline in Clinical Dementia Rating Scale Sum of Boxes (CDR-SB) Total Score After 12-week TreatmentBaseline and 12 weeks

The CDR-SB is obtained through semi-structured interviews of patients and informants, and cognitive functioning was rated in 6 domains of functioning: memory, orientation, judgment and problem solving, community affairs, home and hobbies and personal care. Each domain was rated on a 5-point scale of functioning as follows: 0-no impairment; 0.5-questionable impairment; 1-mild impairment; 2-moderate impairment and 3-severe impairment. Only personal care was scored on a 4-point scale without a 0.5 rating available. The higher the score, the greater the severity of dementia. Least Squares Mean is actually an adjusted mean change from baseline.

Change From Baseline in Alzheimer's Disease Assessment Scale-cognitive Subscale (ADAS-cog11) Total Score After 12-week TreatmentBaseline and 12 weeks

Alzheimer's Disease Assessment Scale-cognitive subscale (ADAS-cog11) is an 11-item cognitive subscale that objectively measures memory, language, orientation, and praxis with a total score range of 0 to 70. The greater the dysfunction, the greater the score. Least Squares Mean is actually an adjusted mean change from baseline.

Trial Locations

Locations (60)

HOP La Pitié Salpêtrière

🇫🇷

Paris, France

Praxis Dr. med. Volker Schumann

🇩🇪

Berlin, Germany

HOP Pellegrin

🇫🇷

Bordeaux, France

HOP Jean Bernard, Géria, Poitiers

🇫🇷

Poitiers, France

Medical Center Senior

🇵🇱

Sopot, Poland

Hospital Senhora Oliveira Guimarães,EPE

🇵🇹

Guimarães, Portugal

AFL Arzneimittelforschung Leipzig GmbH

🇩🇪

Leipzig, Germany

Institut universitaire de geriatrie Sherbrooke

🇨🇦

Quebec, Canada

Azienda Ospedaliera Careggi

🇮🇹

Firenze, Italy

HOP Gui de Chauliac

🇫🇷

Montpellier, France

HOP Bocage

🇫🇷

Dijon, France

Royal United Hospital

🇬🇧

Bath, United Kingdom

Non-Public Outpatient Clinic Neuromed M. i M. Nastaj

🇵🇱

Lublin, Poland

emovis GmbH

🇩🇪

Berlin, Germany

Ninewells Hospital & Medical School

🇬🇧

Dundee, Scotland, United Kingdom

St. Josef- und St. Elisabeth-Hospital gGmbH

🇩🇪

Bochum, Germany

Neuro Centrum Science GmbH

🇩🇪

Erbach, Germany

Universitätsklinikum Ulm

🇩🇪

Ulm, Germany

Brain Research Center

🇳🇱

Amsterdam, Netherlands

Zentralinstitut für seelische Gesundheit

🇩🇪

Mannheim, Germany

P.O. Bellaria IRCCS Istituto delle scienze Neurologiche di Bologna

🇮🇹

Bologna, Italy

Re-Cognition Health

🇬🇧

Plymouth, United Kingdom

Indiana University

🇺🇸

Indianapolis, Indiana, United States

Azienda Ospedaliera di Parma

🇮🇹

Parma, Italy

Bioclinica Research

🇺🇸

Orlando, Florida, United States

Richmond Behavioral Associates

🇺🇸

Staten Island, New York, United States

Psychiatry And Alzheimer's Care of Rochester, PLLC

🇺🇸

Rochester, New York, United States

Brussels-UNIV Brugmann -Horta

🇧🇪

Brussel, Belgium

The Memory Clinic

🇺🇸

Bennington, Vermont, United States

Private Practice for Psychiatry and Neurology

🇦🇹

Wien, Austria

ANI Neurology, PLLC, dba Alzheimer's Memory Center

🇺🇸

Charlotte, North Carolina, United States

AZ Sint-Blasius

🇧🇪

Dendermonde, Belgium

Mons - UNIV Ambroise Paré

🇧🇪

Mons, Belgium

UNIV UZ Gent

🇧🇪

Gent, Belgium

University of Calgary

🇨🇦

Calgary, Alberta, Canada

Pasqua Hospital

🇨🇦

Regina, Saskatchewan, Canada

HOP Timone

🇫🇷

Marseille, France

HOP Nord Laënnec

🇫🇷

Nantes, France

Podlassian Center of Psychogeriatry, Bialystok

🇵🇱

Bialystok, Poland

Jeroen Bosch Ziekenhuis-Hertogenbosch

🇳🇱

's-HERTOGENBOSCH, Netherlands

Mental Health Center Biomed

🇵🇱

Kielce, Poland

West Devon (Tavistock) CMHT & Memory Clinic (EDI)

🇬🇧

Ivybridge, United Kingdom

Tulsa Clinical Research, LLC

🇺🇸

Tulsa, Oklahoma, United States

Premiere Research Institute

🇺🇸

West Palm Beach, Florida, United States

California Neuroscience Research

🇺🇸

Sherman Oaks, California, United States

Memory Enhancement Center of America, Inc.

🇺🇸

Eatontown, New Jersey, United States

Universitätsmedizin der Johannes Gutenberg-Universität Mainz

🇩🇪

Mainz, Germany

Neurologie und Psychiatrie / Psychotherapie

🇩🇪

Westerstede, Germany

Hospital Fernando Fonseca, EPE

🇵🇹

Amadora, Portugal

Hospital de Braga-Escala Braga

🇵🇹

Braga, Portugal

Inst. of Rural Health, Spec. Outp. Clin. & Rural Occup. Dis.

🇵🇱

Lublin, Poland

Reg. Specialist Hospital Wroclaw, Research & Develop. Center

🇵🇱

Wroclaw, Poland

Non-Public Outpatient Clinic Neuro-Kard Ilkowski & Partners

🇵🇱

Poznan, Poland

CHLO, EPE - Hospital Egas Moniz

🇵🇹

Lisboa, Portugal

EUROMEDIS Sp. z o.o., Szczecin

🇵🇱

Szczecin, Poland

Hospital Beatriz Ângelo

🇵🇹

Loures, Portugal

Dr. Alexander McIntyre Inc.

🇨🇦

Penticton, British Columbia, Canada

CHUC - Centro Hospitalar e Universitário de Coimbra, EPE

🇵🇹

Coimbra, Portugal

ULSM, EPE - Hospital Pedro Hispano

🇵🇹

Matosinhos, Portugal

Centro Hospitalar de Entre o Douro e Vouga, E.P.E. - Hospital de São Sebastião

🇵🇹

Santa Maria da Feira, Portugal

© Copyright 2025. All Rights Reserved by MedPath